Here, we define the specific contributions of the inflammasome sensor NLRP3 to the pathogenesis of MPN by adopting two strategies, genetic deletion and pharmacological inhibition, to inactivate NLRP3 in a conditional JAK2V617F-driven mouse model of MPN. This evidence concerns the gene NLRP3 and myeloproliferative neoplasm.